(688626)"XIANGYU MEDICAL CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 688626 · · 13 pages · Chinese
Summary by 6ix AI
The report indicates a decline in net profit attributable to shareholders compared to the same period last year, alongside a decrease in operating income. The company also reported a significant drop in cash flow from operating activities during the quarter. Overall, the report emphasizes the board's commitment to the accuracy and completeness of the financial information provided.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Xiangyu Medical Co., Ltd. on 6ix
Earlier from Xiangyu Medical
- Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Medical Device and Medical Equipment Industry
- Announcement on Providing Counter-guarantee for Financing Loans of the Investee Company
- Indicative Announcement on Expiration of Lock-up Period and Achievement of Unlocking Conditions under 2025 Employee Stock Ownership Plan
- Announcement on Resolutions of the 12th Meeting of the 3rd Board of Directors
Follow Xiangyu Medical into a list and get an email when it puts out news.
Follow Xiangyu Medical